FITB:NASDAQFifth Third Bancorp Analysis
Data as of 2026-05-22 - not real-time
$49.16
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Fifth Third Bancorp (FITB) is trading at $49.16, just below its 20‑day SMA of $49.19 but comfortably above the 50‑day ($48.00) and 200‑day ($46.66) averages, indicating a still‑bullish medium‑term trend. The stock sits on a solid support level around $46.80 with resistance near $51.25, while the RSI of 51.9 suggests neutral momentum and the MACD histogram remains in bearish territory, hinting at possible short‑term pressure. Volume is increasing, volatility over the past 30 days is elevated at 22.9%, and beta hovers around 1.0, reflecting market‑aligned risk. Fundamentally, FITB posted a remarkable 33% revenue growth, maintains a healthy profit margin of 24.1%, and its forward PE of 10.0 is well below the industry average of 16.7, supporting a value narrative. The dividend yield of 3.25% with a payout ratio near 53% appears sustainable given strong operating cash flow. Analysts collectively rate the stock as a Buy with a median target of $57, implying roughly 16% upside from current levels. Recent material news – upbeat Q1 earnings, a strategic acquisition of a multifamily lending platform, and active participation in the Morgan Stanley Financials Conference – reinforce confidence in growth prospects. However, the bearish MACD and proximity to the resistance zone caution against aggressive short‑term buying. Overall, the blend of solid fundamentals, attractive dividend, and positive sentiment positions FITB as a compelling hold with upside potential, while short‑term volatility warrants a measured approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram suggests near‑term weakness
- Price approaching resistance at $51.25
- Strong dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 33% revenue growth and improving forward earnings
- Forward PE of 10 versus industry average 16.7
- Analyst consensus Buy with median target $57
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend yield of 3.25% and moderate payout ratio
- Robust profitability metrics (ROE ~8%) and low leverage relative to equity
- Strategic acquisitions expanding multifamily lending capabilities
Key Metrics & Analysis
Financial Health
Revenue Growth33.00%
Profit Margin24.13%
P/E Ratio16.6
ROE7.97%
ROA0.85%
P/B Ratio1.4
Op. Cash Flow$2.2B
Industry P/E16.7
Technical Analysis
TrendBullish
RSI51.9
Support$46.80
Resistance$51.25
MA 20$49.19
MA 50$48.00
MA 200$46.66
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5
Valuation
Fair Value$43.80
Target Price$57.40
Upside/Downside16.75%
GradeFair
TypeBlend
Dividend Yield3.25%
Risk Assessment
Beta1.02
Volatility22.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.